CEO Andrew Simpson Discusses HeartSciences’ AI-ECG Solutions
HeartSciences’ CEO Andrew Simpson discusses heart disease and our AI-ECG solutions using both MyoVista hardware and MyoVista Insights cloud-based solutions
See the video:
Millions of ECGs are performed every week, however, for decades these tests have largely remained unchanged. Conventional ECGs are easy and quick to perform, but unfortunately do not detect most heart disease conditions.
Artificial Intelligence-Enhanced Electrocardiography (AI-ECG) is set to transform cardiovascular medicine. AI-ECG allows previously unseen disease to be identified and radically expands the clinical usefulness of an ECG.
Investor Relations:
Integrous Communications
Mark Komonoski
Partner
Phone: 877-255-8483
Email: mkomonoski@integcom.us
Media Contact:
HeartSciences
Gene Gephart
Phone: +1-682-244-2578 Ext. 2024
Email: info@heartsciences.com